Neuropace, Inc. NPCE Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s additional paid-in capital?
- Neuropace, Inc. (NPCE) reported additional paid-in capital of $573.52M in Q1 2026.
- How has Neuropace, Inc.'s additional paid-in capital changed year-over-year?
- Neuropace, Inc.'s additional paid-in capital increased by 2.1% year-over-year, from $561.78M to $573.52M.
- What is the long-term trend for Neuropace, Inc.'s additional paid-in capital?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s additional paid-in capital has grown at a 19.0% compound annual growth rate (CAGR), from $239.83M to $571.41M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.